Scale of Therapeutic Adherence to Respiratory Rahabilitation for Lung Cancer

Last updated: June 21, 2024
Sponsor: Instituto Nacional de Cancerologia de Mexico
Overall Status: Active - Recruiting

Phase

N/A

Condition

Non-small Cell Lung Cancer

Lung Disease

Lung Cancer

Treatment

Scale of Therapeutic Adherence to Respiratory Rahabilitation for Lung Cancer (STA-RR-LC)

Clinical Study ID

NCT06477302
(023/039/ICI)(CEI/045/23)
  • Ages > 18
  • All Genders

Study Summary

The goal of this non experimental, transversal instrument study is to Construct and determine the reliability and validity of the Scale of Therapeutic Adherence for Respiratory Rehabilitation in Lung Cancer in Mexican patients with a lung cancer diagnosis.

The main question it aims to answer is: What is the reliability and validity of the Scale of Therapeutic Adherence for Respiratory Rehabilitation in Lung Cancer of the patients with this diagnosis that are currently undergoing an assessment or follow up program of Respiratory Rehabilitation?

The Scale of Therapeutic Adherence for Respiratory Rehabilitation in Lung Cancer (STA-RR-LC) will be psychometrically valid and reliable for the evaluation of therapeutic adherence on patients with lung cancer that are undergoing an assessment or follow up of Respiratory Rehabilitation.Participants will be asked to fill out an Identification card and fill out the fifty-six items presented on the STA-RR-LC.

Eligibility Criteria

Inclusion

Inclusion Criteria:

  • Patients diagnosed with lung cancer (SCLC and NSCLC).

  • Over 18 years of age.

  • Voluntary participation by understanding and accepting the informed consent letter.

  • Patients undergoing Respiratory Rehabilitation treatment with one month assessmentand follow-up.

  • Patients in active medical treatment.

  • Any clinical stage.

  • Karnofsky Index ≥ 70.

Exclusion

Exclusion Criteria:

  • Severe hearing or visual problems that prevent them from understanding theinstructions and answering the instruments (this will be identified as reported inthe clinical record file).

  • Severe psychiatric conditions (schizophrenia or psychotic disorders) and/oraddiction to any psychoactive substance (this will be identified as reported in theINCanet file).

  • Attentional or memory problems that prevent them from understanding the instructionsand answering the instruments (this will be identified as reported in the INCanetfile).

Study Design

Total Participants: 281
Treatment Group(s): 1
Primary Treatment: Scale of Therapeutic Adherence to Respiratory Rahabilitation for Lung Cancer (STA-RR-LC)
Phase:
Study Start date:
June 23, 2023
Estimated Completion Date:
June 23, 2026

Study Description

For the recruitment patients with lung cancer diagnosis that arrive at the Respiratory Rehabilitation service will be asked if they are willing to participate and fill out the STA.

It will be explained to them as clearly as possible the objective, procedure, risks and benefits of the study and a copy of the Informed Consent will be provided. Lung cancer patients attending the Pulmonary Rehabilitation service will be approached and a verbal explanation of the study will be given.

Connect with a study center

  • Instituto Nacional de Cancerologia

    Mexico City, 14080
    Mexico

    Active - Recruiting

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.